The Sanger Institute and personalised genomics
19 Dec 2017
The Sanger Institute and personalised genomics
Worrying results from genotyping quality assessments
Focus on screening, not biomarkers
Could personalised medicine increase inequality to medicine access?
Creating a culture of shared data
The Innovative Medicines Initiative
Results of the AML 12 trial
Why we are not ready for personalised medicine
Genetically profiling entire populations, starting with Estonia
How does ancestry affect your health?
Neuroblastoma and cell communication networks
Personalised medicine differs from precision medicine